These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 9230182)

  • 1. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney.
    Liao SY; Aurelio ON; Jan K; Zavada J; Stanbridge EJ
    Cancer Res; 1997 Jul; 57(14):2827-31. PubMed ID: 9230182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of MN/CA9 gene expression in identifying malignant solid renal tumors.
    Li G; Cuilleron M; Cottier M; Gentil-Perret A; Lambert C; Genin C; Tostain J
    Eur Urol; 2006 Feb; 49(2):401-5. PubMed ID: 16387417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of G250/mn/CA9 antigen by flow cytometry: its possible implication for detection of micrometastatic renal cancer cells.
    Li G; Passebosc-Faure K; Lambert C; Gentil-Perret A; Blanc F; Oosterwijk E; Mosnier JF; Genin C; Tostain J
    Clin Cancer Res; 2001 Jan; 7(1):89-92. PubMed ID: 11205923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas.
    Uemura H; Nakagawa Y; Yoshida K; Saga S; Yoshikawa K; Hirao Y; Oosterwijk E
    Br J Cancer; 1999 Oct; 81(4):741-6. PubMed ID: 10574265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MN/CA IX antigen as a potential target for renal cell carcinoma].
    Uemura H; Cho M; Nakagawa Y; Shimizu K; Yoshikawa M; Kim S; Hirao Y
    Hinyokika Kiyo; 2000 Oct; 46(10):745-8. PubMed ID: 11215204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CA9 as a molecular marker for differential diagnosis of cystic renal tumors.
    Li G; Bilal I; Gentil-Perret A; Feng G; Zhao A; Peoc'h M; Genin C; Tostain J; Gigante M
    Urol Oncol; 2012; 30(4):463-8. PubMed ID: 20822935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9.
    McKiernan JM; Buttyan R; Bander NH; de la Taille A; Stifelman MD; Emanuel ER; Bagiella E; Rubin MA; Katz AE; Olsson CA; Sawczuk IS
    Cancer; 1999 Aug; 86(3):492-7. PubMed ID: 10430258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms.
    Gupta R; Balzer B; Picken M; Osunkoya AO; Shet T; Alsabeh R; Luthringer D; Paner GP; Amin MB
    Am J Surg Pathol; 2009 Feb; 33(2):241-7. PubMed ID: 18941400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
    Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M
    Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase IX (CA9) expression in multiple renal epithelial tumour subtypes.
    Baniak N; Flood TA; Buchanan M; Dal Cin P; Hirsch MS
    Histopathology; 2020 Oct; 77(4):659-666. PubMed ID: 32639054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clear cell meningioma: a clinicopathologic study of 18 tumors and examination of the use of CD10, CA9, and RCC antibodies to distinguish between clear cell meningioma and metastatic clear cell renal cell carcinoma.
    Prayson RA; Chamberlain WA; Angelov L
    Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):422-8. PubMed ID: 20453815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human kidney injury molecule-1 (hKIM-1): a useful immunohistochemical marker for diagnosing renal cell carcinoma and ovarian clear cell carcinoma.
    Lin F; Zhang PL; Yang XJ; Shi J; Blasick T; Han WK; Wang HL; Shen SS; Teh BT; Bonventre JV
    Am J Surg Pathol; 2007 Mar; 31(3):371-81. PubMed ID: 17325478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of circulating MN/CA9 positive renal cell carcinoma cells during operation.
    Uemura H; Nakagawa Y; Iwai A; Okajima E; Okajima E; Yoshikawa K; Hirao Y
    Aktuelle Urol; 2003 Jul; 34(4):270-2. PubMed ID: 14566683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MN/CA9 gene expression as a potential biomarker in renal cell carcinoma.
    Murakami Y; Kanda K; Tsuji M; Kanayama H; Kagawa S
    BJU Int; 1999 May; 83(7):743-7. PubMed ID: 10368188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of MN/CA IX antigen in carcinogenesis and metastasis of renal cell carcinoma].
    Nakagawa Y; Uemura H; Shimizu K; Cho M; Yoshikawa M; Hirao Y; Yoshikawa K
    Hinyokika Kiyo; 2001 Nov; 47(11):809-14. PubMed ID: 11771176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid and sensitive detection of messenger RNA expression for molecular differential diagnosis of renal cell carcinoma.
    Li G; Cuilleron M; Gentil-Perret A; Cottier M; Passebosc-Faure K; Lambert C; Genin C; Tostain J
    Clin Cancer Res; 2003 Dec; 9(17):6441-6. PubMed ID: 14695146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CA9 level in renal cyst fluid: a possible molecular diagnosis of malignant tumours.
    Li G; Feng G; Cuilleron M; Zhao A; Gentil-Perret A; Cottier M; Genin C; Tostain J
    Histopathology; 2009 Jun; 54(7):880-4. PubMed ID: 19469910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of MN/CAIX in the diagnosis of renal cell carcinoma].
    Jiang YD; Ren F; Zheng SB
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):412-4. PubMed ID: 22445996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody 'Renal Cell Carcinoma Marker'.
    McGregor DK; Khurana KK; Cao C; Tsao CC; Ayala G; Krishnan B; Ro JY; Lechago J; Truong LD
    Am J Surg Pathol; 2001 Dec; 25(12):1485-92. PubMed ID: 11717537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
    Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
    Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.